NASDAQ:TCON

TRACON Pharmaceuticals Short Interest Ratio and Short Volume

$7.40
-0.66 (-8.19 %)
(As of 04/19/2021 10:58 AM ET)
Add
Compare
Today's Range
$7.31
Now: $7.40
$7.80
50-Day Range
$7.56
MA: $8.68
$9.65
52-Week Range
$1.55
Now: $7.40
$12.20
Volume1,002 shs
Average Volume442,596 shs
Market Capitalization$114.54 million
P/E RatioN/A
Dividend YieldN/A
Beta2.02

Short Interest

TRACON Pharmaceuticals (NASDAQ:TCON) Short Interest Data

Current Short Volume496,000 shares
Previous Short Volume481,400 shares
Change Vs. Previous Month:+3.03%
Dollar Volume Sold Short$3.90 million
Short Interest Ratio / Days to Cover1.1
Last Record DateMarch, 31 2021
Outstanding Shares29,940,000 shares
Float Size14,820,000 shares
Short Percent of Float3.35%
Today's Trading Volume1,002 shares
Average Trading Volume442,596 shares
Today's Volume Vs. Average-99.77%

Short Interest Over Time


TRACON Pharmaceuticals (NASDAQ:TCON) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2021496,000 shares $3.90 million +3.0%3.4%1.1 $7.87
3/15/2021481,400 shares $3.83 million +37.4%3.3%0.8 $7.96
2/26/2021350,500 shares $3.14 million -37.5%2.4%0.6 $8.95
2/12/2021560,500 shares $5.24 million +56.7%4.3%0.9 $9.35
1/29/2021357,800 shares $3.81 million +7.5%2.8%0.4 $10.65
1/15/2021332,800 shares $3.03 million -39.3%2.6%0.4 $9.10
12/31/2020179,300 shares $1.95 million +34.0%1.4%0.2 $10.90
12/15/2020179,300 shares $1.82 million +34.0%1.4%0.2 $10.15
11/30/2020133,800 shares $1.05 million -41.3%1.0%0.1 $7.83
11/15/2020228,100 shares $2.29 million +6.1%1.8%0.2 $10.04
10/30/2020215,000 shares $1.64 million -7.5%1.7%0.1 $7.63
10/15/2020232,300 shares $1.11 million -32.4%1.9%0.1 $4.76
9/30/2020343,500 shares $1.93 million -35.4%4.3%0.2 $5.61
9/15/2020531,900 shares $2.56 million +115.2%6.6%0.3 $4.81
8/31/2020247,200 shares $1.01 million +779.7%3.1%0.2 $4.08
8/14/202028,100 shares $67,721.00 -54.6%0.4%0 $2.41
7/31/202061,900 shares $111,420.00 -49.1%0.8%0.1 $1.80
7/15/2020121,500 shares $200,475.00 +66.4%2.5%0.3 $1.65
6/30/202073,000 shares $133,590.00 +322.0%1.5%0.2 $1.83
6/15/202017,300 shares $33,562.00 -23.1%0.4%0.1 $1.94
5/29/202022,500 shares $42,525.00 -46.9%0.5%0.1 $1.89
5/15/202042,400 shares $97,520.00 +66.9%0.9%0.2 $2.30
4/30/202025,400 shares $52,070.00 -56.4%0.5%0.1 $2.05
4/15/202058,200 shares $116,400.00 -27.2%1.3%0.2 $2.00
3/31/202079,900 shares $144,619.00 -14.9%1.7%0.2 $1.81

TRACON Pharmaceuticals (NASDAQ:TCON) Short Interest FAQ

speech bubbles
speech bubbles











What is TRACON Pharmaceuticals' current short interest?

Short interest is the volume of TRACON Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 496,000 shares of TCON short. 3.35% of TRACON Pharmaceuticals' shares are currently sold short. View details.

What is a good short interest ratio for TRACON Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TRACON Pharmaceuticals currently has a short interest ratio of 1.0.

What is a good short interest percentage for TRACON Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.35% of TRACON Pharmaceuticals' floating shares are currently sold short.

Is TRACON Pharmaceuticals' short interest increasing or decreasing?

TRACON Pharmaceuticals saw a increase in short interest in March. As of March 31st, there was short interest totaling 496,000 shares, an increase of 3.0% from the previous total of 481,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is TRACON Pharmaceuticals' float size?

TRACON Pharmaceuticals currently has issued a total of 15,479,000 shares. Some of TRACON Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TRACON Pharmaceuticals currently has a public float of 14,820,000 shares.

How does TRACON Pharmaceuticals' short interest compare to its competitors?

3.35% of TRACON Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to TRACON Pharmaceuticals: Aptose Biosciences Inc. (5.86%), Freeline Therapeutics Holdings plc (0.09%), AVROBIO, Inc. (0.00%), Gritstone Oncology, Inc. (8.79%), Jounce Therapeutics, Inc. (4.54%), Opthea Limited (0.00%), Lineage Cell Therapeutics, Inc. (0.00%), SQZ Biotechnologies (3.83%), Fusion Pharmaceuticals Inc. (1.72%), and Innate Pharma S.A. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.84 billion), Aon plc ($5.47 billion), Charter Communications, Inc. ($5.36 billion), ViacomCBS Inc. ($3.99 billion), Snap Inc. ($3.77 billion), Airbnb, Inc. ($2.90 billion), Peloton Interactive, Inc. ($2.43 billion), Discovery, Inc. ($2.38 billion), The Kroger Co. ($2.28 billion), and Expedia Group, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short TRACON Pharmaceuticals stock?

Short selling TCON is an investing strategy that aims to generate trading profit from TRACON Pharmaceuticals as its price is falling. TRACON Pharmaceuticals' stock is trading down $0.66 today. To short TRACON Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that TRACON Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against TRACON Pharmaceuticals?

A short squeeze for TRACON Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TCON, which in turn drives the price of the stock up even further.

How often is TRACON Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCON, twice per month. The most recent reporting period available is March, 31 2021.



This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.